¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15
±³À°ÀÏÀÚ : 2018-09-15
±³À°Àå¼Ò : ¼¼ºê¶õ½ºº´¿ø Á¾ÇÕ°ü 337È£ °­ÀǽǠ 
±³À°ÁÖÁ¦ : AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : AML/MDS¿¬±¸È¸  
´ã´çÀÚ : Á¤¼¼¿µ
¿¬¶ôó : 02-533-1408  
À̸ÞÀÏ : seiyoung@yuhs.ac      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 25ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 09:50~10:20 Long term use of hypomethylating agents for MDS  Á¤ÁØ¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 10:20~10:50 JALSG AML/MDS/CMML Clinical observational study -Preliminary report of the MDS part-  Kensuke Usuki(NTT Medical Center Tokyo) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 10:50~11:20 Genetic mutations and decision-making of treatment options for MDS  ±èÀ¯Áø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 11:20~11:50 Preliminary report of AZA trial for high risk MDS, MDS212 on behalf of JALSG  Yasushi Miyazaki(Nagasaki University) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 11:50~12:05 Study Proposal (I)- Prospective study of the indUction Regimen for acute non-Promyelocytic myeloid Leukemia in Elderly Hypomethylating agents for favorable risk (PURPLE-H)   ±èÇõ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 12:05~12:20 Study Proposal (II) - Beyond hypomethylating agent (HMA) failure in AML patients  ¹Ú½Çºñ¾Æ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 12:20~12:35 Study Proposal (III) - Comparative study on MDS between Korea and Japan  Yasushi Miyazaki(Nagasaki University) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 13:30~13:55 Decision between epigenetic therapy and chemotherapy in patients with AML  ÀÌÇý¿ø(±¹¸³¾Ï¼¾Å¸) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 13:55~14:20 Genomics of Myeloid Malignancies  Á¶¿µ¿í(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 14:30~14:55 Target Therapy  ½Åµ¿¿±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09¿ù 15ÀÏ Á¾ÇÕ°ü 337È£ 14:55~15:20 CAR-T Therapy, Immune Checkpoint and Vaccine Approaches in AML  ÀåÁØÈ£(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼¼ºê¶õ½ºº´¿ø ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ : 2018-09-15
´ÙÀ½±Û °í·Á´ëÇб³ ±¸·Îº´¿ø Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ ÀÇ»çÁ÷À» À§ÇÑ ÀÇ·áÀ±¸® ½ÉÆ÷Áö¾ö : 2018-09-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20763 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ»ç) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-06-11 0 44 2024-05-27
20762 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Á¦ 32ȸ Á¤±â Áý´ãȸ : 2024-06-10 0 65 2024-05-27
20761 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø Á¦16ȸ KOALA Symposium 2024 : 2024-06-09 0 51 2024-05-27
20760 ¼­¿ï 2024³âµµ ¼¼ºê¶õ½ºº´¿ø IBD¼ÒÈ­±â³»°ú ¿¬¼ö°­Á : 2024-06-09 0 44 2024-05-27
20759 ºÎ»ê 2024³â ¿µ³² ½ÉÃÊÀ½ÆÄ ¿¬¼ö°­Á : 2024-06-09 0 20 2024-05-27
20758 ¼­¿ï 2024 ´ëÇÑÆòÇüÀÇÇÐȸ Á¦46Â÷ Ãá°èÇмú´ëȸ ¹× Á¦13Â÷ ±³À°°­Á : 2024-06-09 0 19 2024-05-27
20757 ¼­¿ï ´ëÇÑ°üÀý°æÇÐȸ – Á¦11ȸ °üÀý°æ ¼ö¼ú ½ÉÆ÷Áö¾ö : 2024-06-09 0 45 2024-05-27
20756 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Çѱ¹ÀÓ»ó¿¹¼úÇÐȸ ÇÏ°èÇмú´ëȸ ¹× ¿öÅ©¼ó : 2024-06-09 0 24 2024-05-27
20755 ¼­¿ï ´ëÇÑÇǺοܰúÇÐȸ KSDS 2nd International Congress SEOUL 2024 (2ÀÏÂ÷) : 2024-06-09 0 25 2024-05-27
20754 ºÎ»ê ´ëÇѺñ´¢ÀÇÇÐȸ Á¦88ȸ ºÎ»êºñ´¢ÀÇÇÐÆ÷·³ : 2024-06-08 0 41 2024-05-27
20753 ¼­¿ï 2024 Á¤½Å½ÅüÀÇÇÐ Àü¹®°¡°úÁ¤ º¸¼ö±³À° : 2024-06-08 0 33 2024-05-27
20752 °æ±â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Àü±â°æ·ÃÄ¡·áÀÇ ÃÖ½ÅÁö°ß°ú ÀÓ»óÀû¿ë : 2024-06-08 0 35 2024-05-27
20751 °æ±â 2024 Á¦4ȸ ¿¬¼¼ÀÇ´ë ÀÔ¿øÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-06-08 0 59 2024-05-27
20750 ¼­¿ï (¿Â¶óÀÎ) Á¦74Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 34 2024-05-27
20749 ¼­¿ï 2024 ¼ö¸éÈ£ÈíÀå¾Ö ¿¬±¸È¸ & ÁýÁßÄ¡·á ¿¬±¸È¸ °øµ¿½ÉÆ÷Áö¾ö : 2024-06-08 0 41 2024-05-27
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷